TransCode Therapeutics, Inc.

RNAZNASDAQ Capital Market·USD·Closed

RNAZNASDAQ·USD·Closed

$4.56

−13.14%

$4.56

−$0.69 (13.14%)

52W Range

4thpctl

Volume

0.49×avg

Mkt Cap

4.83MUSD

P/E

-0.1TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

4thpctl

Volume

0.49×avg

Market Cap

4.83MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-21.2%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-4942.7×

Current ratio3.11×